Abstract
In a retrospective study to compare the drug consumption during pregnancy of mothers of infants with congenital abnormalities and of those without, over 97% of 1,369 mothers took prescribed drugs and 65% self-administered drugs. Significantly more mothers of infants with congenital abnormalities took aspirin, antacids, dextroamphetamine, phenobarbitone, sodium amytal, other barbiturates, cough medicines, iron, sulphonamides, and nicotinamide than mothers in the control group. However, most mothers taking analgesics, antacids, appetite suppressants, barbiturates, cough medicines, iron, sulphonamides, and vitamins produced normal infants. Any teratogenic effect of these drugs is therefore one of low potency. On the other hand, deficiencies such as those of ascorbic acid and folic acid may have a teratogenic effect. There is need for caution in presuming teratogenic effects on the basis of the associations shown here. During pregnancy, however, it would appear wise to avoid the administration of any drug which carries a suspicion of teratogenicity unless that drug is specifically indicated, and self-medication with common household remedies such as aspirin and antacids should be avoided. These recommendations would also apply to any woman of childbearing age in whom conception is likely.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Crombie D. L., Pinsent R. J., Slater B. C., Fleming D., Cross K. W. Teratogenic drugs--R.C.G.P. survey. Br Med J. 1970 Oct 17;4(5728):178–179. doi: 10.1136/bmj.4.5728.178-c. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lenz W. Malformations caused by drugs in pregnancy. Am J Dis Child. 1966 Aug;112(2):99–106. doi: 10.1001/archpedi.1966.02090110043001. [DOI] [PubMed] [Google Scholar]
- Mackler B. Studies of the molecular basis of congenital malformations. Pediatrics. 1969 Jun;43(6):915–926. [PubMed] [Google Scholar]
- Meadow S. R. Congenital abnormalities and anticonvulsant drugs. Proc R Soc Med. 1970 Jan;63(1):48–49. [PMC free article] [PubMed] [Google Scholar]
- Milunsky A., Graef J. W., Gaynor M. F., Jr Methotrexate-induced congenital malformations. J Pediatr. 1968 Jun;72(6):790–795. doi: 10.1016/s0022-3476(68)80430-5. [DOI] [PubMed] [Google Scholar]
- Nelson M. M., Forfar J. O. Congenital abnormalities at birth: their association in the same patient. Dev Med Child Neurol. 1969 Feb;11(1):3–16. doi: 10.1111/j.1469-8749.1969.tb01391.x. [DOI] [PubMed] [Google Scholar]
- Nishimura H., Takano K., Tanimura T., Yasuda M., Uchida T. High incidence of several malformations in the early human embryos as compared with infants. Biol Neonat. 1966;10(1):93–107. doi: 10.1159/000240012. [DOI] [PubMed] [Google Scholar]
- Nora J. J., Nora A. H., Sommerville R. J., Hill R. M., McNamara D. G. Maternal exposure to potential teratogens. JAMA. 1967 Dec 18;202(12):1065–1069. [PubMed] [Google Scholar]
- Richards I. D. Congenital malformations and environmental influences in pregnancy. Br J Prev Soc Med. 1969 Nov;23(4):218–225. doi: 10.1136/jech.23.4.218. [DOI] [PMC free article] [PubMed] [Google Scholar]
- TATTERSALL R. BARBITURATE TOXICITY. Practitioner. 1965 Jan;194:68–71. [PubMed] [Google Scholar]
- TRASLER D. G. ASPIRIN-INDUCED CLEFT LIP AND OTHER MALFORMATIONS IN MICE. Lancet. 1965 Mar 13;1(7385):606–607. doi: 10.1016/s0140-6736(65)91192-x. [DOI] [PubMed] [Google Scholar]
- WARKANY J., TAKACS E. Experimental production of congenital malformations in rats by salicylate poisoning. Am J Pathol. 1959 Mar-Apr;35(2):315–331. [PMC free article] [PubMed] [Google Scholar]